Clinical medicine is fairly black and white as I'm sure many of you would agree. If I were to treat a patient diagnosed with a myocardial infarction in Asia, Europe or America I would certainly initiate aspirin (among other cardiac meds) in all cases. Why? Because the evidence for its benefit is global.
Recently I had the pleasure of observing a team based learning (TBL) session at the newly established Lee Kong Chian (LKC) School of Medicine, a joint initiative between Imperial College London and Nanyang Technological University. As a doctor having trained via problem based learning (PBL) I was able to appreciate the stark difference between the two forms of instruction.
My arrival into medical school back in 2001 launched me, not only into a world of systemic disease, but rather a world of information overload. Verbose medical texts were seen scattered across my room with my typical schedule spent inhaling the multitude of odours as expressed by a cohort of 200 plus students during lecture hall gatherings.